ivabradine has been researched along with Auricular Fibrillation in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (5.56) | 29.6817 |
| 2010's | 26 (72.22) | 24.3611 |
| 2020's | 8 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Gluud, C; Jakobsen, JC; Liang, N; Maagaard, M; Nielsen, EE; Sethi, NJ; Yang, SH | 1 |
| Han, Y; Hou, Y; Li, H; Wang, J; Wang, W; Wang, Z; Zhang, A | 1 |
| Haberal, İ; Tekin, EE; Yeşiltaş, MA | 1 |
| Chang, JJ; Chen, MC; Jan, JY; Lin, MS; Lin, YS; Wang, PC; Yang, TY | 1 |
| Chan, YH; Cheung, BM; Hai, JJ; Lau, CP; Tse, HF; Wong, CK | 1 |
| Bueno, H; Fontenla, A; García-Fernandez, FJ; López-Gil, M; Matía, R; Mejía, E; Miracle, A; Montilla, I; Rajjoub, EA; Rey, JR; Salgado, R; Tamargo, J; Toquero, J | 1 |
| Arias, MÁ; Arribas, F; Fontenla, A; Gómez de la Cámara, A; López-Gil, M; Matía-Francés, R; Mejía-Martínez, E; Miracle-Blanco, Á; Montilla, I; Pastor-Fuentes, A; Rey-Blas, JR; Salgado-Aranda, R; Tamargo-Menéndez, J; Toquero-Ramos, J | 1 |
| Francisco-Pascual, J; Rivas-Gándara, N | 1 |
| de Juan, J; Fontenla, A; Giacoman, S; López-Gil, M; Lozano, Á; Villagraz, L | 1 |
| Caminiti, G; Campolongo, G; Cascelli, G; Fossati, C; Punzo, N; Volterrani, M | 1 |
| Koenig, SN; Mohler, PJ | 1 |
| Jacobshagen, C | 1 |
| Belardinelli, L; Kanas, AF; Machado, AD; Nearing, BD; Pagotto, VP; Sobrado, LF; Sobrado, MF; Varone, BB; Verrier, RL; Zeng, D | 1 |
| Cazeau, S; Cohen Solal, A; Logeart, D; Moubarak, G | 1 |
| Bourke, JP; Keavney, BD; Koref, MS; Martin, RI; Pogoryelova, O; Teare, MD | 1 |
| Cowie, MR | 1 |
| Batatinha, JA; Belardinelli, L; Bonatti, R; Liu, G; Nearing, BD; Rajamani, S; Silva, AF; Verrier, RL; Zeng, D | 2 |
| Bollmann, A; Hilbert, S; Hindricks, G; John, S; Kosiuk, J; Oebel, S | 1 |
| Hong, YF; Ji, YT; Jiang, T; Li, JX; Li, YD; Tang, BP; Xing, Q; Xiong, J; Yusufuaji, Y; Zhou, XH | 1 |
| Ferrari, R; Ford, I; Fox, K; Steg, PG; Tardif, JC; Tendera, M | 1 |
| Caminiti, G; Fossati, C; Rosano, G; Volterrani, M | 1 |
| Lüscher, TF | 1 |
| Abdel-Salam, Z; Nammas, W | 1 |
| Davis, K; Dietrich, E | 1 |
| Aksakal, E; Aksu, U; Gulcu, O; Kaymaz, C; Oduncu, V; Sevimli, S; Tanboğa, İH; Topçu, S; Ulusoy, FR | 1 |
| Başaran, Ö; Biteker, M; Doğan, V; Ergün, G | 1 |
| Li, G; Li, K; Liu, T; Liu, XS; Lu, Y; Zhang, N | 1 |
| Bollmann, A; Hindricks, G; Kosiuk, J; Lindemann, F | 1 |
| Cahoon, WD; Francis, KE; Lowe, DK; Turley, SL | 1 |
| Gunaparn, S; Phrommintikul, A; Ruttanaphol, A; Wongcharoen, W | 1 |
| Fukumitsu, M; Inagaki, M; Kawada, T; Li, M; Sugimachi, M; Uemura, K; Zheng, C | 1 |
| Bögeholz, N; Dechering, DG; Eckardt, L; Ellermann, C; Fehr, M; Frommeyer, G; Kochhäuser, S; Pott, C; Sterneberg, M | 1 |
| Hannon, JD; Housmans, PR | 1 |
| Aliyev, F; Celiker, C; Türkoğlu, C; Uzunhasan, I | 1 |
| Swedberg, K | 1 |
8 review(s) available for ivabradine and Auricular Fibrillation
| Article | Year |
|---|---|
Ivabradine added to usual care in patients with heart failure: a systematic review with meta-analysis and trial sequential analysis.
Topics: Atrial Fibrillation; Bradycardia; Heart Failure; Humans; Ivabradine; Myocardial Infarction; Quality of Life | 2022 |
Ivabradine and Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.
Topics: Atrial Fibrillation; Humans; Ivabradine; Randomized Controlled Trials as Topic; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2022 |
[Late sodium current and calcium overload--pathogenesis and adequate treatment].
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Atrial Fibrillation; Benzazepines; Calcium; Calcium Channel Blockers; Cardiovascular Agents; Coronary Artery Disease; Electrocardiography; Endothelium, Vascular; Heart Failure, Diastolic; Humans; Hypercalcemia; Ivabradine; Myocardial Ischemia; Nitrates; Piperazines; Ranolazine; Sodium; Sodium Channels; Sodium-Calcium Exchanger | 2013 |
Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials.
Topics: Angina Pectoris; Atrial Fibrillation; Benzazepines; Heart Failure; Humans; Incidence; Ivabradine; Randomized Controlled Trials as Topic; Risk Assessment | 2014 |
Ivabradine (Corlanor) for Heart Failure.
Topics: Atrial Fibrillation; Benzazepines; Bradycardia; Cardiovascular Agents; Drug Costs; Heart Failure; Humans; Hypertension; Ivabradine; Treatment Outcome | 2016 |
The Risk of Atrial Fibrillation With Ivabradine Treatment: A Meta-analysis With Trial Sequential Analysis of More Than 40000 Patients.
Topics: Aged; Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Chi-Square Distribution; Coronary Disease; Female; Humans; Incidence; Ivabradine; Male; Middle Aged; Odds Ratio; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors | 2016 |
Emerging role of ivabradine for rate control in atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Benzazepines; Cyclic Nucleotide-Gated Cation Channels; Electrocardiography; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged | 2016 |
Ca2+: is there something new for the cardiovascular anesthesiologist?
Topics: Anesthesia; Atrial Fibrillation; Benzazepines; Calcium; Calcium Signaling; Cardiotonic Agents; Cardiovascular Surgical Procedures; Heart Rate; Humans; Ivabradine; Myosins; Sarcoplasmic Reticulum; Sick Sinus Syndrome | 2009 |
5 trial(s) available for ivabradine and Auricular Fibrillation
| Article | Year |
|---|---|
Ivabradine for controlling heart rate in permanent atrial fibrillation: A translational clinical trial.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Digoxin; Heart Rate; Humans; Ivabradine | 2023 |
Ivabradine for chronic heart rate control in persistent atrial fibrillation. Design of the BRAKE-AF project.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Agents; Digoxin; Equivalence Trials as Topic; Heart Rate; Humans; Ivabradine; Treatment Outcome | 2020 |
Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study.
Topics: Aged; Atrial Fibrillation; Benzazepines; Bradycardia; Cardiovascular Agents; Coronary Artery Disease; Double-Blind Method; Female; Humans; Ivabradine; Male; Middle Aged; Risk Factors | 2015 |
Metoprolol vs ivabradine in patients with mitral stenosis.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Electrocardiography; Female; Follow-Up Studies; Humans; Ivabradine; Male; Metoprolol; Middle Aged; Mitral Valve Stenosis; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Ivabradine reduced ventricular rate in patients with non-paroxysmal atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Double-Blind Method; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Prospective Studies | 2016 |
23 other study(ies) available for ivabradine and Auricular Fibrillation
| Article | Year |
|---|---|
Short-Term Results of Ivabradine versus Metoprolol: The Effects on Atrial Fibrillation in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting.
Topics: Atrial Fibrillation; Coronary Artery Bypass; Humans; Hypotension; Ivabradine; Metoprolol; Postoperative Complications | 2022 |
Ivabradine in heart failure patients with reduced ejection fraction and history of paroxysmal atrial fibrillation.
Topics: Atrial Fibrillation; Cohort Studies; Heart Failure; Humans; Ivabradine; Stroke Volume; Ventricular Dysfunction, Left | 2022 |
Ventricular rate control with ivabradine in patients with permanent atrial fibrillation.
Topics: Atrial Fibrillation; Heart Ventricles; Humans; Ivabradine | 2022 |
Do we have a new drug for heart rate control in patients with permanent atrial fibrillation?
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Heart Rate; Humans; Ivabradine; Pharmaceutical Preparations | 2020 |
Ivabradine as an Alternative to AV Node Ablation in a Patient With Permanent Atrial Fibrillation.
Topics: Atrial Fibrillation; Atrioventricular Node; Benzazepines; Cardiovascular Agents; Catheter Ablation; Electrocardiography; Humans; Ivabradine; Male; Middle Aged | 2017 |
Dose-dependent effects of ivabradine on heart rate during maximal efforts in a woman with permanent atrial fibrillation.
Topics: Atrial Fibrillation; Benzazepines; Electrocardiography; Female; Heart Rate; Humans; Ivabradine | 2017 |
Potential use of ivabradine for treatment of atrial fibrillation.
Topics: Animals; Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Cyclic Nucleotide-Gated Cation Channels; Ivabradine; Mice; Mice, Transgenic | 2019 |
Inhibition of I(f) in the atrioventricular node as a mechanism for dronedarone's reduction in ventricular rate during atrial fibrillation.
Topics: Amiodarone; Animals; Atrial Fibrillation; Atrioventricular Node; Benzazepines; Cyclic Nucleotide-Gated Cation Channels; Disease Models, Animal; Dronedarone; Drug Therapy, Combination; Electrocardiography; Heart Rate; Heart Ventricles; Ivabradine; Male; Swine; Ventricular Function, Left | 2013 |
Might ivabradine be useful in permanent atrial fibrillation?
Topics: Aged; Atrial Fibrillation; Benzazepines; Electrocardiography, Ambulatory; Female; Hospitalization; Humans; Ivabradine | 2014 |
Ivabradine and atrial fibrillation: what should we tell our patients?
Topics: Angina Pectoris; Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Heart Failure; Heart Rate; Humans; Ivabradine; Medication Therapy Management; Middle Aged; Randomized Controlled Trials as Topic; Risk Assessment | 2014 |
If inhibition in the atrioventricular node by ivabradine causes rate-dependent slowing of conduction and reduces ventricular rate during atrial fibrillation.
Topics: Analysis of Variance; Animals; Atrial Fibrillation; Atrioventricular Node; Benzazepines; Cardiac Catheterization; Cardiovascular Agents; Disease Models, Animal; Electrocardiography; Fluoroscopy; Guinea Pigs; Heart Conduction System; Heart Rate; Infusions, Intravenous; Ivabradine; Male; Pulse Therapy, Drug; Random Allocation; Reference Values; Sus scrofa; Swine; Ventricular Function, Left | 2014 |
Combined actions of ivabradine and ranolazine reduce ventricular rate during atrial fibrillation.
Topics: Animals; Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Drug Therapy, Combination; Guinea Pigs; Heart Rate; Ivabradine; Male; Ranolazine; Swine | 2015 |
Ivabradine for rate control in atrial fibrillation.
Topics: Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Heart Rate; Humans; Ivabradine; Male; Middle Aged | 2015 |
Effects of ivabradine on cardiac electrophysiology in dogs with age-related atrial fibrillation.
Topics: Aging; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzazepines; Cardiac Pacing, Artificial; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Female; Heart Atria; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Male; Pulmonary Veins; Refractory Period, Electrophysiological; Sinoatrial Node | 2015 |
Addition of ivabradine to betablockers in patients with atrial fibrillation: Effects on heart rate and exercise tolerance.
Topics: Aged; Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Cyclic Nucleotide-Gated Cation Channels; Dose-Response Relationship, Drug; Exercise Tolerance; Female; Heart Rate; Humans; Ivabradine; Male | 2016 |
Supraventricular and ventricular arrhythmias.
Topics: Anticoagulants; Arrhythmogenic Right Ventricular Dysplasia; Atrial Fibrillation; Benzazepines; Bradycardia; Cardiovascular Agents; Heart Diseases; Hemorrhage; Humans; Ivabradine; Point-of-Care Systems | 2015 |
Atrial Fibrillation After Coronary Artery Bypass Surgery: Can Ivabradine Reduce Its Occurrence?
Topics: Action Potentials; Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzazepines; Bisoprolol; Coronary Artery Bypass; Coronary Artery Disease; Drug Administration Schedule; Drug Therapy, Combination; Egypt; Elective Surgical Procedures; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Pilot Projects; Prospective Studies; Time Factors; Treatment Outcome | 2016 |
Ivabradine and atrial fibrillation: A double-edged sword.
Topics: Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Humans; Ivabradine | 2016 |
Need for further studies on ivabradine in patients with persistent atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzazepines; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Needs Assessment; Treatment Outcome | 2016 |
Acute ivabradine treatment reduces heart rate without increasing atrial fibrillation inducibility irrespective of underlying vagal activity in dogs.
Topics: Animals; Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Dogs; Electric Stimulation; Electrophysiological Phenomena; Female; Heart Atria; Heart Rate; Ivabradine; Male; Vagus Nerve | 2017 |
Effective suppression of atrial fibrillation by ivabradine: Novel target for an established drug?
Topics: Action Potentials; Animals; Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Drug Delivery Systems; Ivabradine; Organ Culture Techniques; Rabbits; Treatment Outcome | 2017 |
Successful use of ivabradine in a case of exaggerated autonomic dysfunction.
Topics: Adult; Atrial Fibrillation; Autonomic Nervous System Diseases; Benzazepines; Electrocardiography; Humans; Ivabradine; Male; Postural Orthostatic Tachycardia Syndrome; Syncope | 2010 |
Heart failure management. Interview with Karl Swedberg.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Benzazepines; Benzimidazoles; Biphenyl Compounds; Cardiac Output, Low; Chronic Disease; Defibrillators, Implantable; Humans; Ivabradine; Practice Guidelines as Topic; Tetrazoles; Ventricular Dysfunction, Left | 2007 |